US Patent Issued to Guangzhou Realbenefitspot Pharmaceutical on Nov. 11 for "Use of trimanganese tetraoxide particles in preparation of vaccine adjuvant" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,634, issued on Nov. 11, was assigned to Guangzhou Realbenefitspot Pharmaceutical Co. Ltd. (Guangzhou, China).

"Use of trimanganese tetraoxide particles in preparation of vaccine adjuvant" was invented by Yaling Wang (Guangzhou, China), Chunying Chen (Guangzhou, China) and Yuliang Zhao (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a use of trimanganese tetraoxide particles in preparation of a vaccine adjuvant. The adjuvant is a particle adjuvant, the particle adjuvant is trimanganese tetraoxide particles externally wrapped with or without an excipient, and the particle size of the particle adjuvant is 5 nm to 3000 nm. ...